GLSV co-finances Sandoz spin-off Nabriva GmbH(02/02/2006) Global Life Science Ventures (GLSV) announced the launch of Nabriva GmbH, a specialist antibiotic research and development company that has existed until now within Sandoz GmbH as the Vienna-based Antibiotic Research Institute (ABRI). GLSV is ...
Sandoz Files Lawsuit Seeking FDA Ruling on Omnitrope(09/16/2005) Sandoz announced that it has filed a lawsuit against the US Food and Drug Administration, seeking a ruling on its pending new drug application for the human growth hormone Omnitrope."We believe it is important for patients and health-care providers ...
Sandoz, Inc. to Drop Challenge to PROVIGIL(R) Patent(05/04/2005) Cephalon, Inc. reported that Sandoz, Inc. has notified Cephalon that it will no longer challenge Cephalon's U.S. particle-size modafinil patent. Instead, Sandoz said it intends to convert its abbreviated new drug application (ANDA) for approval of a ...
Top
